Latest news

9 Jul 2020 News
Analyzing immune responses of hematological cancers could inform immunotherapy options
9 Jul 2020 Breast
Paradigm II: a new model of the interactions between breast cancer causes
2 Jul 2020 Pancreatic
Artificial intelligence is poised to overhaul pancreatic cancer screening
23 Jun 2020 News
Berzosertib: new precision medicine shows promise in advanced tumors

Video

View all videos

1 Jun 2020 Events Coverage
ASCO20 virtual annual meeting: Editors’ highlights

Video

View all videos

Features

Interviews

Spotlights

Journal articles

Stay up to date

Upcoming event

Molecular Analysis for Personalised Therapy Congress 2020

October 8, 2020 – October 10, 2020

Amsterdam, Netherlands

View all

Upcoming event

ESMO World Congress of Gastrointestinal Cancer 2020

July 1, 2020 – July 4, 2020

Barcelona, Spain

View all

Tweets

Oncology Central @OncologyCentral·

#pembrolizumab monotherapy: outcomes for PD-L1–positive (TPS ≥50%) metastatic #NSCLC at US oncology practices https://t.co/sQYYjUeNNy

View all

Jobs

Connecting talent with opportunity. View our featured jobs

View all

Our mission statement

At Oncology Central we are dedicated to advancing oncology by publishing trusted, engaging and insightful resources for the global oncology community.

Learn more

Analyzing immune responses of hematological cancers could inform immunotherapy options

Paradigm II: a new model of the interactions between breast cancer causes

Artificial intelligence is poised to overhaul pancreatic cancer screening

Berzosertib: new precision medicine shows promise in advanced tumors

The best of 2019: an A–Z of cancer research and care

The future of liquid biopsies: an interview with Bob Li

Pharma, President, Patients: the cancer cost conundrum

How could a “pre-cancer genome atlas” transform cancer prevention?

Panel discussion: the future of oncology

Unlocking the power of the cancer genome: an interview with Phil Febbo, Illumina Inc.

Exploring the Thyroid Imaging Reporting and Data System (TI-RADS): an interview with Franklin Tessler

Video

ASCO20 virtual annual meeting: Editors’ highlights

Video

Login

Latest news

Analyzing immune responses of hematological cancers could inform immunotherapy options

Paradigm II: a new model of the interactions between breast cancer causes

Artificial intelligence is poised to overhaul pancreatic cancer screening

Berzosertib: new precision medicine shows promise in advanced tumors

Featured articles

The best of 2019: an A–Z of cancer research and care

The future of liquid biopsies: an interview with Bob Li

Pharma, President, Patients: the cancer cost conundrum

How could a “pre-cancer genome atlas” transform cancer prevention?

Panel discussion: the future of oncology

Unlocking the power of the cancer genome: an interview with Phil Febbo, Illumina Inc.

Exploring the Thyroid Imaging Reporting and Data System (TI-RADS): an interview with Franklin Tessler

Video

ASCO20 virtual annual meeting: Editors’ highlights

Video

Does switching from olaparib capsules to tablets increase toxicity in ovarian cancer patients?

Pembrolizumab monotherapy: outcomes for PD-L1–positive (TPS ≥50%) metastatic NSCLC at US oncology practices

How could comprehensive genomic profiling bring cancer from uncertainty to focus?

In Focus: lung cancer

Addressing unmet needs in pancreatic cancer with Pascal Hammel

Tumor clonality and resistance mechanisms in EGFR mutation-positive NSCLC: implications for therapeutic sequencing

Features

Interviews

Spotlights

Journal articles

Stay up to date

Oncology Central Newsletter